Clinical trial Recruiting at 1 site Observational Ages 18 to 26

Assessing gait using a smartphone application

Official title: Validity and Reliability of a Smartphone Application for Gait Assessment

Run by Istanbul University - Cerrahpasa · NCT06157749 · Data updated 2026-11-12

This study is testing a smartphone app for measuring walking patterns to see if it works as well as traditional methods for healthy young adults.

Quick facts

Study typeObservational
Ages18 Years to 26 Years
SexAll
Enrollment34 (estimated)
SponsorIstanbul University - Cerrahpasa
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedJuly 31, 2024
Main results expectedJuly 2025
Study endsSeptember 2025
Registry record updatedMarch 24, 2025
Trial IDNCT06157749 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy individuals aged 18 to 26 with a normal body mass index.

Probably not a fit

Patients with lower extremity rotational problems, recent injuries, or any neurological or musculoskeletal disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the Gait-Analyzer smartphone application compared to traditional 3D computerized gait analysis. Healthy participants aged 18 to 26 will be recruited and divided into two groups to undergo both types of gait analysis. The aim is to determine the validity and reliability of the smartphone application in assessing human gait, which is crucial for clinical decision-making. By leveraging the accessibility of smartphone technology, the study seeks to address the limitations of conventional gait analysis methods.

Why it matters

Potential benefit: If successful, this study could provide a more accessible and cost-effective method for gait analysis in clinical settings.

How similar studies have gone: While the use of smartphone applications for gait analysis is emerging, this specific comparison with the gold standard has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 26 years.
* Body Mass Index (BMI) within normal limits (18.5-24.9 kg/m2)

Exclusion Criteria:

* Presence of lower extremity rotational problems (such as high femoral anteversion, internal tibial torsion, metatarsus adductus).
* History of Botulinum Toxin Type A (BoNT-A) application or surgery within the last 6 months.
* History of lower extremity injury within the last 6 months.
* Leg length discrepancy.
* Presence of third-degree pes planus.
* Any neurological, rheumatic, musculoskeletal, metabolic, or connective tissue diseases.
* History of pain, deformity, or surgery related to the vertebral column and upper extremities.
* Presence of cognitive, mental, and/or severe psychiatric disorders

Where it's running

  • Acibadem Mehmet Ali Aydinlar University
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.